EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

De novo Crohn’s Disease Treated with Ustekinumab in a Pediatric Liver Transplant Recipient with Tyrosinemia: A Case Report

Saray Mesonero-Cavia, Marta Freixas-Bermejo, Marina Álvarez-Beltran, Susana Redecillas-Ferreiro, Vanessa Cabello-Ruiz, Judith Raya-Muñoz, Maria Mercadal-Hally, Andrea Martin-Nalda, Oscar Segarra-Cantón

Case Reports in Gastroenterology · 02.04.2026 · 20 (1) · 138-148

DOI: 10.1159/000551716 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Gastroenterology, online erschienen am 02.04.2026. Verfasst von Saray Mesonero-Cavia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology and Nutritional Unit, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

De novo inflammatory bowel disease (IBD) is more frequent in transplant recipients than in the general population and should be considered in the differential diagnosis of chronic diarrhea. In pediatric liver transplant recipients, an incidence of 206 vs. 20 cases per 100,000 patient-years has been reported, suggesting an underrecognized complication of immunosuppression. Case Presentation: We report an 11-year-old girl with tyrosinemia type 1 who underwent liver transplantation and later developed de novo Crohn’s disease. Despite maintenance therapy with tacrolimus, methylprednisolone, and everolimus, she presented with chronic diarrhea, weight loss, and elevated inflammatory markers after several episodes of Clostridioides difficile infection treated with oral vancomycin and only transient improvement. Initial inflammatory markers were only mildly elevated but showed a progressive rise over 18 months despite antibiotic therapy, alongside positive ASCA IgG and ASCA IgA with negative pANCA at the time of formal evaluation. Colonoscopy showed patchy aphthous and serpiginous ulcers with a cobblestone appearance, and histology revealed cryptitis and a mixed lymphoplasmacytic infiltrate without granulomas. Magnetic resonance enterography demonstrated ileocolic inflammation with wall thickening and mesenteric vessel engorgement. Infectious and drug-induced colitis and Epstein-Barr virus-related disease were excluded, and de novo ileocolic Crohn’s disease (Paris A1b L3 B1 G1) was diagnosed. Ustekinumab (260 mg intravenously, then 90 mg subcutaneously every 4 weeks) was added to baseline immunosuppression, inducing clinical remission with normalization of C-reactive protein and a decrease in fecal calprotectin to 10 µg/g by week 20, sustained at 18 months with preserved graft function.

Conclusion

This case illustrates the diagnostic challenges of de novo Crohn’s disease in pediatric liver transplant recipients with metabolic liver disease and supports ustekinumab as a safe and effective option when other biologics are limited by prior infectious or lymphoproliferative.

Schlagwörter

Stichwörter der Autor:innen

De novo Crohn’s diseaseInflammatory bowel diseasePediatric liver transplantTyrosinemiaUstekinumab

Autor:innen und Institutionen

  • Pediatric Gastroenterology and Nutritional Unit, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Pediatric Hepatology and Liver Transplantation Unit, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall Hebron Barcelona Hospital Campus, Barcelona, Spain.

Zitieren

APA

Mesonero-Cavia, S., Freixas-Bermejo, M., Álvarez-Beltran, M., Redecillas-Ferreiro, S., Cabello-Ruiz, V., Raya-Muñoz, J., Mercadal-Hally, M., Martin-Nalda, A., & Segarra-Cantón, O. (2026). De novo Crohn’s Disease Treated with Ustekinumab in a Pediatric Liver Transplant Recipient with Tyrosinemia: A Case Report. Case Reports in Gastroenterology, 20(1), 138-148. https://doi.org/10.1159/000551716

Vancouver

Mesonero-Cavia S, Freixas-Bermejo M, Álvarez-Beltran M, Redecillas-Ferreiro S, Cabello-Ruiz V, Raya-Muñoz J, et al. De novo Crohn’s Disease Treated with Ustekinumab in a Pediatric Liver Transplant Recipient with Tyrosinemia: A Case Report. Case Reports in Gastroenterology. 2026;20(1):138-148. doi:10.1159/000551716

BibTeX
@article{MesoneroCavia2026,
  author = {Mesonero-Cavia, Saray and Freixas-Bermejo, Marta and Álvarez-Beltran, Marina and Redecillas-Ferreiro, Susana and Cabello-Ruiz, Vanessa and Raya-Muñoz, Judith and Mercadal-Hally, Maria and Martin-Nalda, Andrea and Segarra-Cantón, Oscar},
  title = {De novo Crohn’s Disease Treated with Ustekinumab in a Pediatric Liver Transplant Recipient with Tyrosinemia: A Case Report},
  journal = {Case Reports in Gastroenterology},
  year = {2026},
  volume = {20},
  number = {1},
  pages = {138--148},
  doi = {10.1159/000551716}
}
Kostenlos starten →